Cargando…

Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin‐induced diabetic rats

Diabetic cardiomyopathy is characterized by diastolic and systolic cardiac dysfunction, yet no therapeutic drug to specifically treat it. Hexarelin has been demonstrated to improve heart function in various types of cardiomyopathy via its receptor GHS‐R. This experiment aims to test the effect of he...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinli, Qu, Linbing, Chen, Ling, Chen, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812882/
https://www.ncbi.nlm.nih.gov/pubmed/29446246
http://dx.doi.org/10.14814/phy2.13612

Ejemplares similares